These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38139284)

  • 1. Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis.
    Kwakowsky A; Chawdhary B; de Souza A; Meyer E; Kaye AH; Green CR; Stylli SS; Danesh-Meyer H
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tonabersat suppresses priming/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease.
    Cliff CL; Squires PE; Hills CE
    Cell Commun Signal; 2024 Jul; 22(1):351. PubMed ID: 38970061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury.
    Roger E; Chadjichristos CE; Kavvadas P; Price GW; Cliff CL; Hadjadj S; Renciot J; Squires PE; Hills CE
    Cell Commun Signal; 2023 Sep; 21(1):263. PubMed ID: 37770948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
    Front Immunol; 2018; 9():2588. PubMed ID: 30464764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.
    Mugisho OO; Aryal J; Shome A; Lyon H; Acosta ML; Green CR; Rupenthal ID
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model.
    Takase EO; Yamasaki R; Nagata S; Watanabe M; Masaki K; Yamaguchi H; Kira JI; Takeuchi H; Isobe N
    Sci Rep; 2024 May; 14(1):10877. PubMed ID: 38740862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease.
    Mugisho OO; Rupenthal ID; Paquet-Durand F; Acosta ML; Green CR
    Expert Opin Ther Targets; 2019 Oct; 23(10):855-863. PubMed ID: 31554417
    [No Abstract]   [Full Text] [Related]  

  • 8. Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.
    Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Fakour M; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Tashakori-Miyanroudi M; Roghani M
    J Mol Neurosci; 2021 Feb; 71(2):215-224. PubMed ID: 32812186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice.
    Hou B; Yin J; Liu S; Guo J; Zhang B; Zhang Z; Yang L; Tan X; Long Y; Feng S; Zhou J; Wu Y; Wang X; Han S; Wang Z; He X
    Mol Neurobiol; 2024 Mar; 61(3):1318-1330. PubMed ID: 37702910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination.
    Une H; Yamasaki R; Nagata S; Yamaguchi H; Nakamuta Y; Indiasari UC; Cui Y; Shinoda K; Masaki K; Götz M; Kira JI
    J Neuroinflammation; 2021 Jun; 18(1):126. PubMed ID: 34090477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy.
    Lyon H; Shome A; Rupenthal ID; Green CR; Mugisho OO
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.
    Lang Y; Chu F; Liu L; Zheng C; Li C; Shen D; Liu S; Zhang W; Cui L; Zhu J
    Clin Exp Immunol; 2022 May; 207(3):378-386. PubMed ID: 35553640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis.
    Contarini G; Franceschini D; Facci L; Barbierato M; Giusti P; Zusso M
    J Neuroinflammation; 2019 Jun; 16(1):126. PubMed ID: 31221190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease.
    Mat Nor MN; Rupenthal ID; Green CR; Acosta ML
    Neurotherapeutics; 2020 Jan; 17(1):371-387. PubMed ID: 31637594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
    de Toledo JHDS; Fraga-Silva TFC; Borim PA; de Oliveira LRC; Oliveira EDS; Périco LL; Hiruma-Lima CA; de Souza AAL; de Oliveira CAF; Padilha PM; Pinatto-Botelho MF; Dos Santos AA; Sartori A; Zorzella-Pezavento SFG
    Front Immunol; 2020; 11():571844. PubMed ID: 33193354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
    Barclay W; Shinohara ML
    Brain Pathol; 2017 Mar; 27(2):213-219. PubMed ID: 27997058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model.
    Sharma S; Risen S; Gilberto VS; Boland S; Chatterjee A; Moreno JA; Nagpal P
    ACS Chem Neurosci; 2024 Apr; 15(7):1596-1608. PubMed ID: 38526238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking connexin 43 hemichannel-mediated ATP release reduces communication within and between tubular epithelial cells and medullary fibroblasts in a model of diabetic nephropathy.
    Williams BM; Cliff CL; Demirel I; Squires PE; Hills CE
    Diabet Med; 2022 Dec; 39(12):e14963. PubMed ID: 36256487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
    Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
    J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis.
    Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Esmaeil-Jamaat E; Fahanik-Babaei J; Fakour M; Fereidouni F; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Sanaierad A; Zahedi E; Roghani M
    J Chem Neuroanat; 2021 Jan; 111():101891. PubMed ID: 33217488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.